Mayo Clinic Precure - Prospective Study
NCT07332598 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 100000
Last updated 2026-03-16
Summary
The goal of this observational study is to 1) better understand and predict biological processes before disease begins or is identified, 2) study genomic and environmental contributors to disease, 3) identify ways to stop disease advancement before it becomes serious or complex, and 4) identify potential targets for disease therapy.
Participants will be asked to:
* collect biological samples,
* download a mobile app,
* collect speech (voice) recordings, and
* complete surveys
Conditions
- Genetic Predisposition
- Exposure, Environmental
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Konstantinos N. Lazaridis, M.D. · Mayo Clinic
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-01-19
- Primary Completion
- 2030-12-31
- Completion
- 2035-12-31
Countries
- United States
Study Locations
More Related Trials
-
Proteomics and Genomics Combined With CT to Predict CVD
NCT05800093 ·Status: ACTIVE_NOT_RECRUITING
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
NCT05819814 ·Status: RECRUITING ·Phase: NA
-
Prospective Electronic Polygenic Risk Study - Second Phase
NCT05175651 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Aging, Geriatric Syndromes and Clonal Hematopoiesis
NCT02604563 ·Status: RECRUITING
-
Predictive Medicine Research. (PRE MED)
NCT00336570 ·Status: COMPLETED
-
Inflammation Markers Over Time in Cardiovascular Disease
NCT00005692 ·Status: COMPLETED
-
MyLeukoMAP™ Genomic Survival Prediction Assay Pivotal Clinical Study
NCT05258942 ·Status: UNKNOWN
-
Endothelial Cell Gene Networks of CVD
NCT03529916 ·Status: WITHDRAWN
-
Prospective Electronic Polygenic Risk Study
NCT05072275 ·Status: UNKNOWN
-
Genetic Risk Stratification for Primary Prevention of CAD in Men and Pre & Post-menopausal Women
NCT05169840 ·Status: UNKNOWN
-
Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
NCT06311708 ·Status: RECRUITING
-
Identification of Genes Predisposing to Atherosclerosis
NCT00059098 ·Status: COMPLETED
-
Personalized Medicine Decision-Making in a Virtual Clinical Setting
NCT02108041 ·Status: COMPLETED
-
Precision PCI Registry
NCT06143709 ·Status: ACTIVE_NOT_RECRUITING
-
Polygenic Risk Score for Optimizing Primary Prevention in Intermediate-Risk Populations
NCT07039123 ·Status: RECRUITING ·Phase: NA
-
Landscape of Gout in French Polynesia.
NCT07343336 ·Status: RECRUITING
-
Identifying Genes Involved in Abnormal Blood Pressure - Hypertension SCOR
NCT00005325 ·Status: COMPLETED
-
Epidemiology: Oxidative Stress and Early Atherosclerosis
NCT00005393 ·Status: COMPLETED
-
Thrombogenic Factors and Recurrent Coronary Events
NCT00005358 ·Status: COMPLETED
-
Impact of Race/Ethnicity on Platelet Function
NCT01168622 ·Status: COMPLETED
-
Identification of Genes Expressed in Atherosclerotic Plaque
NCT00353730 ·Status: COMPLETED
-
Registry for Mayo Clinic Adult Congenital Heart Disease Control Population
NCT05773300 ·Status: ACTIVE_NOT_RECRUITING
-
Inflammatory Genomics in Human Carotid Artery Disease
NCT00070668 ·Status: COMPLETED
-
Human Lipoprotein Pathophysiology - Subproject: Genetics of Familial Combined Hyperlipidemia
NCT00005313 ·Status: COMPLETED
-
The Microbiome as a Target for Precision Medicine in Atherosclerosis
NCT03434483 ·Status: COMPLETED